Page last updated: 2024-09-04

dx 8951 and pemetrexed

dx 8951 has been researched along with pemetrexed in 1 studies

Compound Research Comparison

Studies
(dx 8951)
Trials
(dx 8951)
Recent Studies (post-2010)
(dx 8951)
Studies
(pemetrexed)
Trials
(pemetrexed)
Recent Studies (post-2010) (pemetrexed)
7318152,4696571,695

Protein Interaction Comparison

ProteinTaxonomydx 8951 (IC50)pemetrexed (IC50)
Thymidylate synthase Escherichia coli1.1
Dihydrofolate reductaseHomo sapiens (human)4.0309
Dihydrofolate reductaseLacticaseibacillus casei2.3
Thymidylate synthaseHomo sapiens (human)8.1787
Dihydrofolate reductaseEscherichia coli K-122.3
Folate receptor betaHomo sapiens (human)0.2585
Folate receptor alphaHomo sapiens (human)0.2417
Trifunctional purine biosynthetic protein adenosine-3Homo sapiens (human)0.0342
Bifunctional purine biosynthesis protein ATICHomo sapiens (human)0.07
Reduced folate transporterHomo sapiens (human)0.0928
Bifunctional dihydrofolate reductase-thymidylate synthaseToxoplasma gondii1.655
Proton-coupled folate transporterHomo sapiens (human)0.0229

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chua, YJ; Cunningham, D1

Reviews

1 review(s) available for dx 8951 and pemetrexed

ArticleYear
Chemotherapy for advanced pancreatic cancer.
    Best practice & research. Clinical gastroenterology, 2006, Volume: 20, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Deoxycytidine; Fluorouracil; Gemcitabine; Glutamates; Guanine; Humans; Irinotecan; Organoplatinum Compounds; Palliative Care; Pancreatic Neoplasms; Pemetrexed; Taxoids; Topoisomerase I Inhibitors

2006